SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is actively discussed following the recent finalization of its Ask Sage acquisition, enhancing its secure generative AI offerings for defense and regulated sectors. This strategic move, coupled with significant debt reduction plans involving new share issuance, has ignited strong community interest comparing it to Palantir and fueling expectations for major contract announcements in critical geopolitical and security domains. The debate around potential dilution from future share authorization balances the widespread anticipation for sustained growth.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending amidst significant geopolitical events tied to Donald Trump's actions in Venezuela, particularly the capture of Nicolas Maduro. The community is sharply divided, with supporters viewing the developments as a decisive move that could benefit the company and lead to a short squeeze, while critics voice concerns over legality and motives, framing it as a distraction. This politically charged environment continues to drive highly speculative sentiment around the stock.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending amid strong community anticipation for regulatory clarity, especially regarding the Clarity Act, which is widely seen as a catalyst for increased institutional adoption and XRPL utility. Discussions are highlighting a diminishing supply with significant token lock-ups and rising demand, fueling optimism for its crucial role in global finance. Further excitement stems from developments like the potential Ripple National Trust Bank and integrations with major retail payment systems.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

The Invesco QQQ Trust is trending as market participants keenly react to the US military operation in Venezuela and the capture of Nicolas Maduro. Community discussion is sharply divided between those anticipating significant market upside from potential lower oil prices and new US economic leverage, and those concerned about escalating geopolitical instability and perceived market manipulation. This event is driving a fervent debate on the future direction of tech-heavy indices amidst these global developments.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is actively trending as Bitcoin gains strength, sparking community discussion around the company's valuation as a leveraged proxy for the digital asset. Investors are keenly focused on the upcoming MSCI index reclassification, a decision that could significantly influence institutional investment flows into MSTR.

Memecoin on Injective taken over by the community.

Nonja

Nonja ($NONJA) is trending as a high-leverage play on Injective's ($INJ) robust ecosystem, which is gaining attention for its strong fundamentals, significant developer activity, and institutional interest with staked ETF filings. The community is actively touting $NONJA as a resilient and organically growing top memecoin on the Injective network, positioning it for substantial gains as its parent chain expands.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is trending with significant premarket gains as recent geopolitical developments in Venezuela, a nation with massive oil reserves, position the company uniquely. The community is actively discussing Chevron's strategic advantage as the sole major U.S. oil operator there, driving bullish sentiment amid global supply considerations.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA CRYPTO) is trending as a high-performance Layer 1 infrastructure, with the community buzzing about its verified 11M+ transactions per second and compliance-first architecture. The recent live integration of Bridge, a Stripe-owned fiat anchor enabling seamless on/off-ramps to regulated banking systems, positions KTA as an undervalued play for global financial plumbing and institutional adoption.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is experiencing a notable surge, trending amidst a broader rally in meme coins and Bitcoin's strong market performance, which has ignited widespread community speculation. Investors are actively debating its immediate future, with many anticipating a significant upward movement, fueled by its iconic meme status and persistent hopes for its role in X payments. This renewed enthusiasm positions Doge as a key focus in the current 'meme season' within the evolving crypto landscape.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after announcing record December and Q4 vehicle deliveries, bringing it close to one million cumulative units. Despite this strong operational performance and approaching profitability, the community is actively debating perceived stock manipulation, arguing that institutional short-selling is keeping shares significantly undervalued amidst its technological advancements like battery swapping.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BioAge Labs (NASDAQ:BIOA) Sets New 52-Week High - Still a Buy?

BioAge Labs (NASDAQ:BIOA) Sets New 12-Month High - Still a Buy...

Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors

Goldman's Small-Cap Biotech Universe: The 2026 Catalyst Playbook For Investors There are just nine days left in the year, and this year has flown by. We've delivered readers a steady stream of 2026...

Paul Rubin Sells 18,000 Shares of BioAge Labs (NASDAQ:BIOA) Stock

BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) insider Paul Rubin sold 18,000 shares of the stock in a transaction that occurred on Tuesday, December 9th. The stock was sold at an average price of...

BioAge Labs (NASDAQ:BIOA) Insider Sells $216,000.00 in Stock

BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) insider Paul Rubin sold 18,000 shares of the business's stock in a transaction that occurred on Tuesday, December 9th. The stock was sold at an...

Paul Rubin Sells 68,897 Shares of BioAge Labs (NASDAQ:BIOA) Stock

BioAge Labs, Inc. (NASDAQ:BIOA - Get Free Report) insider Paul Rubin sold 68,897 shares of the firm's stock in a transaction that occurred on Thursday, December 4th. The stock was sold at an average...

BioAge Labs (NASDAQ:BIOA) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded BioAge Labs from a "sell" rating to a "hold" rating in a report on Saturday...

Jefferies Financial Group Inc. Buys Shares of 50,000 BioAge Labs, Inc. $BIOA

Jefferies Financial Group Inc. bought a new stake in BioAge Labs, Inc. (NASDAQ:BIOA - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities...

BioAge Labs (NASDAQ:BIOA) Issues Quarterly Earnings Results

BioAge Labs (NASDAQ:BIOA - Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.56) EPS for the quarter, beating analysts' consensus estimates of ($0.67) by...

BioAge Labs’ stock&nbsp;lost more than two-thirds of its market cap in pre-market trading Monday, poised to hit an all-time low following its decision to discontinue the STRIDES Phase 2 study of azelaprag, its investigational obesity drug.&nbsp;The halt, announced on Friday, came after some subjects in the azelaprag treatment arms showed elevated liver enzymes, though no clinically significant symptoms were reported.&nbsp;The tirzepatide-only treatment group did not exhibit transaminase elevations, according to the company.CEO Kristen Fortney said, "We made the difficult decision to discontinue the STRIDES Phase 2 study of azelaprag because it became clear that the emerging safety profile of the current doses tested is inconsistent with our goal of a best-in-class oral obesity therapy.”&nbsp;BioAge said it remains focused on developing therapies for metabolic aging and advancing its NLRP3 inhibitor program alongside other research initiatives.The news spurred swift Wall Street downgrades on Monday.&nbsp;Jefferies cut its rating from ‘Buy’ to ‘Hold’ and slashed its price target from $42 to $7, noting the unexpected liver signal after a clean safety profile in eight prior Phase 1 studies by BioAge and Amgen.&nbsp;Citi also downgraded the stock to ‘Neutral’ from ‘Buy’, reducing its price target from $45 to $7. The brokerage highlighted that the liver toxicity concerns significantly limit azelaprag’s potential in obesity treatments and eliminate a key catalyst for BioAge’s shares.<figure class="image"><a href="https://stocktwits.com/symbol/BIOA"><img style="aspect-ratio:1318/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_12_09_at_6_21_42_PM_bad10ec021.png" alt="Screenshot 2024-12-09 at 6.21.42 PM.png" width="1318" height="318"></a><figcaption>BIOA sentiment and message volume on Dec 9 premarket as of 7:45 am ET | source: Stocktwits</figcaption></figure>Retail sentiment on Stocktwits turned sharply ‘bearish’ after the announcement, a reversal from ‘bullish’ levels the previous day.&nbsp;Investors expressed frustration over the trial’s discontinuation and the steep decline in share value.<stembedurl>https://stocktwits.com/ProKnifeCatcher87/message/595559186</stembedurl><stembedurl>https://stocktwits.com/texmade2/message/595509540</stembedurl>BioAge, which had seen strong market interest since its IPO in September amid the weight-loss drug frenzy, is now down over 10% year-to-date.&nbsp;For updates and corrections email newsroom[at]stocktwits[dot]com.

Jefferies cut its rating on BioAge from ‘Buy’ to ‘Hold’ and slashed its price target from $42 to $7

BioAge Stock Nosedives On Obesity Drug Study Halt: Downgrades Crush Retail Sentiment

BioAge, which had seen strong market interest since its IPO in September amid the weight-loss drug frenzy, is now down over 10% year-to-date.

Equity

BioAge, which had seen strong market interest since its IPO in September amid the weight-loss drug frenzy, is now down over 10% year-to-date.


BioAge Labs, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapeutic products for metabolic diseases, such as obesity, by targeting the biology of human beings. It offers Azelaprag, a potential oral therapeutic for obesity, followed by several earlier-stage metabolic programs. The company was founded by Kristen Fortney and Eric Morgen on April 1, 2015 and is headquartered in Emeryville, CA.

BIOA
BioAge Labs Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BIOA News

BIOABioAge Labs Inc.